“We Are in a Clinical Trial”: Why a Registry Listing Is Not an Approval

Clinics offering regenerative hair treatments sometimes say that a therapy is “in clinical trials” or “registered with the FDA.” These phrases can sound reassuring, but they may mean very little. Before paying a Hair Transplant Clinic for any biologic treatment, learn what the terms really signify.

What the FDA says

The FDA’s patient information on regenerative medicine therapies explains that regenerative products need FDA licensure or approval, or must be studied under trial oversight. It warns that a listing on ClinicalTrials.gov does not equal approval, and that registration and listing of an establishment or product do not equal compliance (FDA: Regenerative Medicine Therapies). It also states that products for which patients are charged outside of a trial are likely to be illegal or deceptive.

Why this matters for hair

Many products offered for hair loss fall into the regenerative category, including stem cells, stromal vascular fraction, and exosomes. The American Hair Loss Association states that no exosome product is FDA-approved for hair loss or any condition, and that an IND, which allows a product to be studied, does not equal approval (AHLA: Exosomes). The word “trial” can signal investigation, not proof.

Questions that cut through the language

Ask whether you will be enrolled in a registered study and request the registration identifier. Ask who is sponsoring the study, which institutional review board oversees it, and what the informed consent process involves. Ask whether participants pay to take part, which is unusual in legitimate research, though some trials do involve costs. If the answers are evasive, treat that as a warning.

Trial versus treatment

A true clinical trial has a defined protocol, outcome measures, safety monitoring, and ethical review. A treatment offered for a fee with the label “trial” attached may lack these features. If a clinic describes the same product as a trial for regulatory purposes and as a treatment for marketing purposes, be cautious.

What the research shows

A 2026 systematic review found preliminary human evidence across several regenerative approaches but noted that heterogeneity limits pooled conclusions (Stem Cell Res Ther, 2026). Another review noted the lack of standardized protocols and unknown long-term safety (Egger et al., 2020). Good science is slow, and responsible clinics acknowledge that.

Practical steps

• Search the registry yourself using the study identifier
• Read the actual protocol, not just the summary
• Check whether the facility named is the one offering treatment
• Discuss the offer with an independent physician
• Do not sign consent forms under time pressure

Your rights

You can ask questions, decline, and take time to decide. A legitimate research team respects that. Pressure to commit immediately is not a feature of ethical research.

If you are unsure whether an offer is legitimate, a simple test is to ask for a copy of the informed consent document and the study protocol. Real research teams provide these readily. Read them at home, not in the clinic, and consider asking an independent physician to review them with you. Take your time, and remember that a genuine opportunity will still be there after you have asked your questions. Keep copies of everything you are given, including brochures and consent forms, so that you can review claims later and compare them with what was actually delivered.

Frequently Asked Questions

Does a listing mean the FDA reviewed the treatment?

No. The FDA states that a listing is not approval.

Should I pay to be in a trial?

Be cautious. The FDA warns that charging for products outside a trial is likely illegal or deceptive.

Where can I report concerns?

The FDA’s patient information describes options. The FDA patient page is a good place to start for next steps.

Verify before you trust. Careful patients compare Hair Transplant Clinics on honesty about regulation.